News and Events


Akston Biosciences and LakePharma Announce Strategic Partnership to Manufacture Second-Generation COVID-19 Vaccine

Added on 2021-01-04

A vaccine for everywhere and everyone in the world, AKS-452 is stable for weeks at room temperature, inexpensive to produce, and suitable for both first-time and booster vaccination



Read More

Webinar recording now available: LakePharma’s Coronavirus Spike Protein Antibodies: A fresh quiver of arrows against the crowned invader!

Added on 2020-10-01

Webinar recording available now!!

Read More

LakePharma CEO Hua Tu: 10 Best Inspiring CEOs of 2020

Added on 2020-07-14

By Industry Era

Read More

LakePharma Supplying Mount Sinai with SARS-CoV-2 Proteins for Serological Assays

Added on 2020-05-06

LakePharma today announces that the company will be supplying the Mount Sinai Health System (Mount Sinai) recombinant SARS-CoV-2 spike proteins to the Mount Sinai Laboratory as a component in its blood test for antibody response against SARS-CoV-2, the virus that causes the COVID-19 pandemic.


Read More

Webinar recording now available - Part 2 :LakePharma Reagents & Assays for COVID-19 Antibody Response

Added on 2020-05-04

Recording now available

Read More